PH

Peter Houghton

SH St. Jude Children'S Research Hospital: 4 patents #42 of 351Top 15%
NA Novartis Ag: 1 patents #2,882 of 5,128Top 60%
UO University Of Oklahoma: 1 patents #260 of 608Top 45%
University Of Texas System: 1 patents #2,951 of 6,559Top 45%
📍 Memphis, TN: #296 of 1,908 inventorsTop 20%
🗺 Tennessee: #3,130 of 20,272 inventorsTop 20%
Overall (All Time): #833,000 of 4,157,543Top 25%
6
Patents All Time

Issued Patents All Time

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
10874631 Altertoxin II as a selective inhibitor of Ewing family of tumor cells Susan L. Mooberry, Andrew J Robles, April L. Risinger, Robert H. Cichewicz, Saikat Haldar 2020-12-29
7879868 Use of imatinib (glivec,sti-571) to inhibit breast cancer resistance protein (BCRP)-mediated resistance to therapeutic agents Peter Traxler 2011-02-01
7452717 Compositions and methods for sensitizing and inhibiting growth of human tumor cells Mary K. Danks, Philip M. Potter 2008-11-18
7018631 Compositions and methods for sensitizing and inhibiting growth of human tumor cells Mary K. Danks, Philip M. Potter 2006-03-28
6800483 Compositions and methods for sensitizing and inhibiting growth of human tumor cells Mary K. Danks, Philip M. Potter 2004-10-05
5371081 N-substituted phenoxazines for treating multidrug resistant cancer cells Julie K. Horton, Kuntebommanahalli N. Thimmaiah 1994-12-06